Literature DB >> 20605452

Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation.

Zagaa Odgerel1, Anna Sarkozy, Hee-Suk Lee, Caoimhe McKenna, Julia Rankin, Volker Straub, Hanns Lochmüller, Francalanci Paola, Adele D'Amico, Enrico Bertini, Kate Bushby, Lev G Goldfarb.   

Abstract

Myofibrillar myopathies are a heterogeneous group of neuromuscular disorders characterized by disintegration of myofibrils. The inheritance pattern is commonly autosomal dominant, but there has been a striking absence of secondary cases noted in a BAG3-associated subtype. We studied three families with BAG3 p.Pro209Leu mutation showing a severe phenotype of myofibrillar myopathy and axonal neuropathy with giant axons. In one family, transmission to a pair of siblings has occurred from their asymptomatic father who showed somatic mosaicism. In two other families, neither of the parents was affected or showed detectable level of somatic mosaicism. These observations suggest that the BAG3 variant of myofibrillar myopathy may result from a spontaneous mutation at an early point of embryonic development and that transmission from a mosaic parent may occur more than once. The study underlines the importance of parental evaluation as it may have implications for genetic counseling. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605452      PMCID: PMC2900409          DOI: 10.1016/j.nmd.2010.05.004

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  15 in total

1.  HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy.

Authors:  Serena Carra; Samuel J Seguin; Herman Lambert; Jacques Landry
Journal:  J Biol Chem       Date:  2007-11-15       Impact factor: 5.157

2.  BAG3 deficiency results in fulminant myopathy and early lethality.

Authors:  Sachiko Homma; Masahiro Iwasaki; G Diane Shelton; Eva Engvall; John C Reed; Shinichi Takayama
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

3.  Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases.

Authors:  S Nakano; A G Engel; A J Waclawik; A M Emslie-Smith; N A Busis
Journal:  J Neuropathol Exp Neurol       Date:  1996-05       Impact factor: 3.685

4.  A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy.

Authors:  Matthias Vorgerd; Peter F M van der Ven; Vera Bruchertseifer; Thomas Löwe; Rudolf A Kley; Rolf Schröder; Hanns Lochmüller; Mirko Himmel; Katrin Koehler; Dieter O Fürst; Angela Huebner
Journal:  Am J Hum Genet       Date:  2005-05-31       Impact factor: 11.025

5.  Mutations in ZASP define a novel form of muscular dystrophy in humans.

Authors:  Duygu Selcen; Andrew G Engel
Journal:  Ann Neurol       Date:  2005-02       Impact factor: 10.422

6.  Myotilinopathy: refining the clinical and myopathological phenotype.

Authors:  Montse Olivé; Lev G Goldfarb; Alexey Shatunov; Dirk Fischer; Isidro Ferrer
Journal:  Brain       Date:  2005-06-09       Impact factor: 13.501

7.  Mutations in myotilin cause myofibrillar myopathy.

Authors:  Duygu Selcen; Andrew G Engel
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

8.  Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients.

Authors:  Duygu Selcen; Kinji Ohno; Andrew G Engel
Journal:  Brain       Date:  2004-01-07       Impact factor: 13.501

Review 9.  Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease.

Authors:  Lev G Goldfarb; Marinos C Dalakas
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 10.  Peripheral neuropathy with giant axons and cardiomyopathy associated with desmin type intermediate filaments in skeletal muscle.

Authors:  M Sabatelli; E Bertini; E Ricci; G Salviati; S Magi; M Papacci; P Tonali
Journal:  J Neurol Sci       Date:  1992-05       Impact factor: 3.181

View more
  43 in total

Review 1.  Myofibrillar myopathies: new developments.

Authors:  Montse Olivé; Rudolf A Kley; Lev G Goldfarb
Journal:  Curr Opin Neurol       Date:  2013-10       Impact factor: 5.710

2.  BAG3 (Bcl-2-Associated Athanogene-3) Coding Variant in Mice Determines Susceptibility to Ischemic Limb Muscle Myopathy by Directing Autophagy.

Authors:  Joseph M McClung; Timothy J McCord; Terence E Ryan; Cameron A Schmidt; Tom D Green; Kevin W Southerland; Jessica L Reinardy; Sarah B Mueller; Talaignair N Venkatraman; Christopher D Lascola; Sehoon Keum; Douglas A Marchuk; Espen E Spangenburg; Ayotunde Dokun; Brian H Annex; Christopher D Kontos
Journal:  Circulation       Date:  2017-04-25       Impact factor: 29.690

Review 3.  Proteostasis in cardiac health and disease.

Authors:  Robert H Henning; Bianca J J M Brundel
Journal:  Nat Rev Cardiol       Date:  2017-06-29       Impact factor: 32.419

4.  Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.

Authors:  Pushpa Narayanaswami; Michael Weiss; Duygu Selcen; William David; Elizabeth Raynor; Gregory Carter; Matthew Wicklund; Richard J Barohn; Erik Ensrud; Robert C Griggs; Gary Gronseth; Anthony A Amato
Journal:  Neurology       Date:  2014-10-14       Impact factor: 9.910

5.  Cardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates p38 Signaling.

Authors:  Megan T Quintana; Traci L Parry; Jun He; Cecelia C Yates; Tatiana N Sidorova; Katherine T Murray; James R Bain; Christopher B Newgard; Michael J Muehlbauer; Samuel C Eaton; Akinori Hishiya; Shin Takayama; Monte S Willis
Journal:  Am J Pathol       Date:  2016-06-17       Impact factor: 4.307

6.  Bcl-2-associated athanogene 3 protects the heart from ischemia/reperfusion injury.

Authors:  Feifei Su; Valerie D Myers; Tijana Knezevic; JuFang Wang; Erhe Gao; Muniswamy Madesh; Farzaneh G Tahrir; Manish K Gupta; Jennifer Gordon; Joseph Rabinowitz; Frederick V Ramsey; Douglas G Tilley; Kamel Khalili; Joseph Y Cheung; Arthur M Feldman
Journal:  JCI Insight       Date:  2016-11-17

7.  P209L mutation in Bag3 does not cause cardiomyopathy in mice.

Authors:  Xi Fang; Julius Bogomolovas; Paul Shichao Zhou; Yongxin Mu; Xiaolong Ma; Zee Chen; Lunfeng Zhang; Mason Zhu; Jennifer Veevers; Kunfu Ouyang; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-30       Impact factor: 4.733

8.  Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy.

Authors:  Nadine Norton; Duanxiang Li; Mark J Rieder; Jill D Siegfried; Evadnie Rampersaud; Stephan Züchner; Steve Mangos; Jorge Gonzalez-Quintana; Libin Wang; Sean McGee; Jochen Reiser; Eden Martin; Deborah A Nickerson; Ray E Hershberger
Journal:  Am J Hum Genet       Date:  2011-02-25       Impact factor: 11.025

9.  BAG3 mutation in a patient with atypical phenotypes of myofibrillar myopathy and Charcot-Marie-Tooth disease.

Authors:  Seung Ju Kim; Soo Hyun Nam; Sumaira Kanwal; Da Eun Nam; Da Hye Yoo; Jong-Hee Chae; Yeon-Lim Suh; Ki Wha Chung; Byung-Ok Choi
Journal:  Genes Genomics       Date:  2018-08-25       Impact factor: 1.839

Review 10.  Neuromuscular Diseases Due to Chaperone Mutations: A Review and Some New Results.

Authors:  Jaakko Sarparanta; Per Harald Jonson; Sabita Kawan; Bjarne Udd
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.